Return
- 1M
- 3M
- 6M
- 1Y
- 3Y
- 5Y
This Fund:
Sensex:
BankFD:
Showing Funds Performance since Sep 07, 2020
Fund Overview
Min. investment
SIP ₹100 & Lump. ₹5000
AUM (Fund size)
₹1,240 Cr
Lock In Period
N/A
Expense Ratio
2.14
Benchmark
BSE Healthcare Total Return
Exit Load
0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.
Summary
Latest details for Tata India Pharma & HealthCare Fund Growth include a ₹29.6748 NAV as of Feb 20,2026 and returns since inception of 83.56%. Minimum investments start at SIP ₹100. The Tata India Pharma & HealthCare Fund Growth AUM is ₹1,240 Cr, with a lock-in of N/A years, expense ratio of 2.14%, and benchmark BSE Healthcare Total Return. Exit load is - 0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.. In the growth review for 1M Month/Year, the fund recorded 0.00% returns, against a category average of 0.00% and a category best of 0.00%.
Calculate Returns
You would have got
Your Investment Amount
- 1
- 2
- 3
- 4
- 5
Growth Review
| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|
Portfolio Analysis
- Equity:
- Debt:
- Others
As on: 2026-01-31
View allocation % by
About Fund
Tata India Pharma & HealthCare Fund Growth managed by Tata Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,240 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.14. Under the expert guidance of Rajat Srivastava ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Peer Comparison
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundLIC MF Healthcare Fund Growth | 1 | 78.65 CR | 2.44 |
| This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth | 3 | 812.03 CR | 2.3 |
| This FundTata India Pharma & HealthCare Fund Growth | 3 | 1239.57 CR | 2.14 |
| This FundSBI Healthcare Opportunities Fund Growth | 5 | 3822.73 CR | 1.94 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 5 | 6658.41 CR | 1.86 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundLIC MF Healthcare Fund Growth | 3.2056 | 74.3352 |
| This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth | 7.3931 | 83.5329 |
| This FundTata India Pharma & HealthCare Fund Growth | 6.554 | 83.5614 |
| This FundSBI Healthcare Opportunities Fund Growth | 6.6724 | 92.4655 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 7.1126 | 102.4 |
FAQs
Tata India Pharma & HealthCare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.
The expense ratio of Tata India Pharma & HealthCare Fund Growth is 2.14. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.
Tata India Pharma & HealthCare Fund Growth’s fund performance is as follows:
- 1 Month : %
- 6 Months : %
- 1 Year : %
- 3 Years : %
You can invest in Tata India Pharma & HealthCare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.
The fund size (AUM) of Tata India Pharma & HealthCare Fund Growth is ₹1,240 crore. It changes based on market performance, inflows, and outflows.
You can track your investment in Tata India Pharma & HealthCare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500